Diverticular bleeding is the most common cause of acute lower GI bleeding (LGIB), accounting for 30–65% of cases. [1-3] It results from rupture of the vasa recta at the neck or dome of a diverticulum into the colonic lumen — an arterial bleed that is typically painless but can be large-volume. [1][3] Approximately 70% of cases stop spontaneously, but recurrence is common (up to 40% within 4 years). [2][4]
1. History
- Painless hematochezia is the hallmark — bright red or maroon blood per rectum, often large-volume and abrupt in onset [1][3]
- Mild cramping or bloating may occur (cathartic effect of intraluminal blood), but significant abdominal pain should prompt consideration of alternative diagnoses (e.g., ischemic colitis, diverticulitis) [1]
- Timing: sudden onset, often without prodrome; ask about duration, volume (number of bowel movements, clots), and whether bleeding has slowed or stopped
- Prior episodes of LGIB or known diverticulosis
- Medication history: NSAIDs, aspirin, P2Y12 inhibitors (clopidogrel), anticoagulants (warfarin, DOACs) — all increase risk [3]
- Recent colonoscopy or polypectomy (postpolypectomy bleed mimic)
- Important negatives: absence of weight loss, fever, diarrhea, tenesmus
2. Alarm Features
- Hemodynamic instability: hypotension (SBP <90), tachycardia (HR >100), orthostasis, syncope
- Ongoing brisk bleeding unresponsive to resuscitation
- Hemoglobin drop >2 g/dL from baseline or presenting Hb <7 g/dL
- Signs of hemorrhagic shock (altered mental status, cool/clammy extremities)
- Significant abdominal pain or peritoneal signs → consider ischemic colitis, perforation, or mesenteric ischemia
- Melena or hematemesis → raises concern for an upper GI source (10–15% of patients presenting with hematochezia have an upper GI bleed) [1][5]
3. Medications
Contributors to bleeding
- Aspirin and NSAIDs: pooled RR of LGIB ~1.8; both increase risk of diverticular bleeding via mucosal ulceration at the diverticular dome/neck [3]
- Clopidogrel/P2Y12 inhibitors: independent risk factor; thienopyridine use associated with increased long-term rebleeding (SHR 1.24–1.32) [3][6]
- Anticoagulants (warfarin, DOACs): combination antithrombotic/antiplatelet therapy carries highest risk (incidence 70/1,000 person-years) [3]
- Corticosteroids, opioids may contribute to diverticular disease risk [7]
Management of antithrombotics during acute bleed
- Aspirin for secondary cardiovascular prevention: continue without interruption [5][8]
- Aspirin for primary prevention: discontinue after diverticular bleed [8]
- P2Y12 inhibitors: may be temporarily held; resume within 1–7 days after cessation of bleeding (coordinate with cardiology if recent stent) [5]
- Warfarin: hold on admission; reversal with 4-factor PCC (preferred over FFP) only for life-threatening bleeding with INR substantially exceeding therapeutic range [3]
- DOACs: hold; specific reversal agents (idarucizumab for dabigatran) reserved for life-threatening hemorrhage. Note: andexanet alfa (Andexxa) has been withdrawn from the US market [9-10]
- Tranexamic acid: should be avoided in LGIB — associated with increased thromboembolism and seizure without outcome benefit [8]
4. Diet
- NPO initially if colonoscopy or intervention anticipated
- Unlike diverticulitis, dietary factors have not been clearly implicated in increasing the risk of diverticular hemorrhage [3]
- High-fiber diet is protective against diverticular disease development overall [7]
- No specific dietary restrictions are needed long-term to prevent rebleeding (the old "avoid nuts/seeds" advice is not evidence-based)
- Adequate hydration during and after the acute episode
5. Review of Systems
- GI: hematochezia (volume, frequency, color), melena, hematemesis, abdominal pain, diarrhea, constipation, weight loss, nausea/vomiting
- Cardiovascular: chest pain, dyspnea on exertion, palpitations (anemia symptoms), syncope/presyncope
- Neurologic: lightheadedness, confusion (hemorrhagic shock)
- Constitutional: fever (suggests infectious or inflammatory etiology), fatigue
- Genitourinary: decreased urine output (hypovolemia)
6. Collateral History and Family History
- Confirm medication list with pharmacy/family — particularly anticoagulants and antiplatelets that the patient may not recall
- Prior colonoscopy results (known diverticulosis, polyps, malignancy)
- Family history of colorectal cancer, inflammatory bowel disease, bleeding disorders
- Social history: alcohol use (portal hypertension/varices), NSAID use (OTC)
7. Risk Factors
- Age >50 years (prevalence of diverticulosis increases with age; age >70 is predictive of new-onset diverticular bleeding) [3][11]
- Known diverticulosis — cumulative risk of hemorrhage: 0.21% at 1 year, 2.2% at 5 years, 9.5% at 10 years [3]
- NSAID/aspirin use (HR 2.75 for aspirin; HR 8.61 for NSAIDs in one cohort) [3]
- Anticoagulant/antiplatelet therapy, especially combination regimens [3]
- Right and bilateral diverticulosis (higher bleeding risk than left-sided alone) [3]
- Prior diverticular bleed (strongest predictor of recurrence) [6][11]
- Hypertension, atherosclerotic cardiovascular disease, chronic kidney disease — associated with late rebleeding [12-13]
- Obesity, smoking — risk factors for diverticular disease [7]
8. Differential Diagnosis
- Ischemic colitis: abdominal pain + bloody diarrhea; typically left-sided; pain is a distinguishing feature [1-2]
- Angiodysplasia/arteriovenous malformations: painless bleeding, often right-sided, more common in elderly and those with CKD/aortic stenosis
- Hemorrhoids/anorectal disease: bright red blood on wiping or dripping; usually small volume
- Colorectal neoplasia: may present with occult or overt bleeding; weight loss, change in bowel habits
- Inflammatory bowel disease: bloody diarrhea, abdominal pain, younger patients
- Infectious colitis: fever, diarrhea, travel/exposure history
- Postpolypectomy bleeding: history of recent colonoscopy with polypectomy
- Upper GI bleed masquerading as LGIB: brisk upper GI hemorrhage can present as hematochezia (~10–15% of cases) [1]
- Rectal ulcer (stercoral, NSAID-induced), Dieulafoy lesion, radiation proctopathy: less common [3]
9. Past Medical History
- Prior episodes of LGIB or diverticular bleeding (recurrence up to 25% at 5 years) [6]
- Known diverticulosis on prior colonoscopy
- History of colorectal polyps or cancer
- Cardiovascular disease (impacts antithrombotic management and transfusion thresholds)
- Chronic kidney disease, liver disease (coagulopathy risk)
- Prior abdominal/pelvic surgery or radiation therapy
- Aortic aneurysm repair (aortoenteric fistula — rare but catastrophic)
10. Physical Exam
Vital signs
- tachycardia, hypotension, orthostatic changesshock index[14]
Focused exam
- Abdominal exam: typically benign in diverticular bleeding; tenderness or peritoneal signs suggest alternative diagnosis [1]
- Digital rectal exam (DRE): assess stool color — bright red or maroon stool is typical; melena suggests upper GI or proximal source; blood on DRE is a component of the Oakland score [1][3]
- Anoscopy: to exclude hemorrhoidal or anorectal source [2]
- Skin: pallor, capillary refill, signs of chronic liver disease (spider angiomata, palmar erythema)
- Cardiovascular: murmurs (aortic stenosis — Heyde syndrome with angiodysplasia)
11. Lab Studies
- CBC: hemoglobin/hematocrit (may be falsely normal early in acute bleed; recheck after resuscitation) [5]
- BMP: electrolytes, BUN/creatinine (BUN:Cr ratio >30 may suggest upper GI source)
- Coagulation studies: PT/INR, aPTT (especially if on anticoagulants)
- Type and screen/crossmatch: essential for potential transfusion
- Lactate: if concern for hemodynamic compromise or ischemia
- Liver function tests: if liver disease suspected
- Transfusion threshold: Hb <7 g/dL (restrictive strategy recommended); Hb <8 g/dL in patients with active myocardial ischemia [3][11]
- Platelet target: >50 × 10³/μL before endoscopy; >30 × 10³/μL for severe bleeding [8]
12. Imaging
First-line
- CT angiography (CTA): imaging modality of choice for hemodynamically significant or severe bleeding; sensitivity ~90% for active extravasation; guides embolization if needed [8][11]
- Nearly 80% of patients with negative CTA will have no rebleeding and require no further evaluation [8]
Other modalities
- Colonoscopy is the primary diagnostic/therapeutic tool for hemodynamically stable patients (see Special Tests) [3]
- Tagged RBC scan (Tc-99m scintigraphy): can detect intermittent bleeding at lower flow rates than CTA; not routinely recommended but may be useful for intermittent/obscure bleeding [15-16]
- Conventional angiography: therapeutic (embolization) rather than purely diagnostic; performed after positive CTA [2][15]
When imaging is unnecessary
13. Special Tests
Risk stratification scores
The Oakland Score is the best-validated tool for predicting safe discharge in LGIB. A score ≤8 predicts a 95% probability of safe discharge (sensitivity 98%). [3] The ACG recommends using it to supplement (not replace) clinical judgment. [3]
The following figure illustrates the Oakland Score components:
The following management algorithm outlines the initial evaluation and therapeutic approach based on hemodynamic status:
Other scores include:
- NOBLADS score: predicts severe bleeding (AUROC 0.77) [3]
- Strate score: predicts in-hospital recurrent bleeding [17]
- SHA2PE score: identifies low-risk patients [3]
Point-of-care
- Bedside hemoglobin (iSTAT or similar)
- FAST exam if concern for intra-abdominal pathology
14. ECG
- Obtain ECG in patients with hemodynamic instability, chest pain, known cardiac disease, or significant anemia
- Look for: sinus tachycardia, ST changes/ischemia (demand ischemia from anemia), arrhythmias (atrial fibrillation — relevant to anticoagulation decisions)
- ECG findings may influence transfusion threshold (Hb <8 g/dL if myocardial ischemia present) [11]
15. Assessment
Clinical summary
Diverticular bleeding presents as acute, painless, large-volume hematochezia in a patient with known or suspected diverticulosis. It is an arterial bleed from the vasa recta. The majority of episodes are self-limited (~70%), but bleeding can be brisk and hemodynamically significant, particularly in elderly patients on antithrombotic therapy. [1-2][4]
Severity stratification
- Mild: self-limited bleeding, hemodynamically stable, Hb stable, Oakland score ≤8
- Moderate: requires hospitalization, possible transfusion, hemodynamically stable after resuscitation
- Severe: hemodynamic instability despite resuscitation, ongoing brisk bleeding, need for ICU-level care
Complications
- Hemorrhagic shock
- Transfusion-related complications
- Rebleeding: early (within 30 days) up to 17–24%; late rebleeding cumulative incidence ~15.7% at 5 years [3]
- Ischemic complications from hypotension (AKI, myocardial ischemia, stroke)
16. Treatment Plan
Initial stabilization
- Two large-bore IVs (18G or larger)
- Crystalloid resuscitation targeting normalization of BP and HR [3]
- Telemetry monitoring
- Type and crossmatch; transfuse PRBCs if Hb <7 g/dL (or <8 g/dL with cardiac ischemia) [3]
- Hold anticoagulants; manage antiplatelets per guidelines (see Medications section above)
Definitive management — hemodynamically stable
- Colonoscopy after adequate bowel preparation, ideally within 24 hours of presentation (though early colonoscopy within 24 hours has not demonstrated improved patient-oriented outcomes in stable patients) [2-3][8]
- For stable patients without continued bleeding, colonoscopy within 14 days of spontaneous hemostasis is acceptable [8]
- If stigmata of recent hemorrhage (SRH) identified: endoscopic hemostasis with clips (direct clipping preferred), endoscopic band ligation (EBL), or bipolar coagulation [3]
- EBL may be superior to clipping for reducing early and late rebleeding (early: 8% vs 19%; late: 9% vs 29%) [3]
Definitive management — hemodynamically unstable or ongoing bleeding:
- Perform upper endoscopy first to exclude upper GI source (10–15% of cases) [1][5]
- CTA → if extravasation identified → transcatheter arterial embolization (TAE) [2][15]
- Surgery (segmental or subtotal colectomy): reserved as last resort when endoscopic and angiographic interventions fail [2][16]
The following figure outlines the approach to managing antithrombotic agents during acute LGIB:
17. Disposition
Discharge criteria (outpatient management)
- Oakland score ≤8, self-limited bleeding, hemodynamically stable, no ongoing hematochezia, adequate hemoglobin, reliable follow-up [3]
- Recent colonoscopy (within 12 months) showing diverticulosis with no other concerning findings [8]
Admission criteria
- Oakland score >8, hemodynamic instability, ongoing bleeding, significant anemia requiring transfusion, anticoagulant use with supratherapeutic INR [1][3]
- Older patients with suspected diverticular bleeding should generally be managed inpatient [1]
ICU admission
- Hemodynamically significant bleeding despite initial resuscitation [1]
- Massive transfusion requirement
- Need for emergent angiographic or surgical intervention
Specialist consultation triggers
- GI: all admitted patients for colonoscopy planning
- Interventional radiology: if CTA positive for extravasation or colonoscopy fails
- Surgery: refractory bleeding despite endoscopic and angiographic intervention
- Cardiology: if on dual antiplatelet therapy with recent stent — multidisciplinary decision on antithrombotic management [5][8]
18. Follow Up / Return Precautions
Follow-up timing
- Discharged low-risk patients: outpatient GI follow-up with colonoscopy within 14 days if not performed inpatient [8]
- Post-discharge: PCP follow-up within 1–2 weeks for repeat CBC and medication review
- Ensure colon cancer screening is up to date (new-onset LGIB after anticoagulant initiation may unmask colorectal cancer) [3]
Return precautions — instruct patients to return immediately for:
- Recurrence of bloody stools (any volume)
- Lightheadedness, dizziness, or fainting
- Rapid heart rate or chest pain
- Weakness or inability to stand
Patient counseling
- Recurrence is common: ~15% at 1 year, ~25% at 5 years [3][6]
- Discontinue NSAIDs and aspirin for primary prevention after diverticular bleed [8]
- Review all medications with PCP — minimize unnecessary antithrombotic exposure
- No specific dietary restrictions to prevent rebleeding, but a high-fiber diet supports overall colonic health [3][7]
- Expected recovery: most episodes resolve spontaneously; patients should expect resolution of hematochezia within 24–72 hours
References
1. Colorectal Cancer Screening and Surveillance and Other Colon Conditions in the Older Adult. — Calderwood AH, Shaukat A. The American Journal of Gastroenterology. 2025.
2. Gastrointestinal Surgical Emergencies Textbook. — Ashley E. Aaron, Andrea Amabile, Ciro Andolfi, et al American College of Surgeons (2021). 2021.
3. Management of Patients With Acute Lower Gastrointestinal Bleeding: An Updated ACG Guideline. — Sengupta N, Feuerstein JD, Jairath V, et al. The American Journal of Gastroenterology. 2023.
4. Extravasation and Fluid Collection on Computed Tomography Imaging in Patients With Colonic Diverticular Bleeding. — Takada H, Kadokura M, Yasumura T, et al. PloS One. 2020.
5. Acute Lower Gastrointestinal Bleeding. — Gralnek IM, Neeman Z, Strate LL. The New England Journal of Medicine. 2017.
6. Long-Term Risks of Recurrence After Hospital Discharge for Acute Lower Gastrointestinal Bleeding: A Large Nationwide Cohort Study. — Sato Y, Aoki T, Sadashima E, et al. Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association. 2023.
7. Revised Version Global Guidelines on Diverticular Disease of the Colon: The Fiesole Consensus Report. — Tursi A, Brandimarte G, Di Mario F, et al. Gut. 2025.
8. Management of Acute Lower GI Bleeding: Guidelines From the American College of Gastroenterology. — Hawks MK. American Family Physician. 2024.
9. Anticoagulant Reversal in Gastrointestinal Bleeding: Review of Treatment Guidelines. — Milling TJ, Refaai MA, Sengupta N. Digestive Diseases and Sciences. 2021.
10. FDA Orange Book. — FDA Orange Book. 2026.
11. Emergency Medicine Updates: Lower Gastrointestinal Bleeding. — Long B, Gottlieb M. The American Journal of Emergency Medicine. 2024.
12. Long-Term Natural History of Presumptive Diverticular Hemorrhage. — Wangrattanapranee P, Khrucharoen U, Jensen DM, Jensen ME. The American Journal of Gastroenterology. 2024.
13. Clinical Factors Associated With Severity of Colonic Diverticular Bleeding and Impact of Bleeding Site. — Amano H, Yamamoto T, Ikusaka K, et al. Journal of Clinical Medicine. 2023.
14. Review article: Advances in the management of lower gastrointestinal bleeding. — Alali AA, Almadi MA, Barkun AN. Alimentary Pharmacology & Therapeutics. 2024.
15. ACR Appropriateness Criteria® Radiologic Management of Lower Gastrointestinal Tract Bleeding: 2021 Update. — Karuppasamy K, Kapoor BS, Fidelman N, et al. Journal of the American College of Radiology : JACR. 2021.
16. Acute Lower Gastrointestinal Bleeding: Evaluation and Management. — Hawks MK, Svarverud JE. American Family Physician. 2020.
17. Comparison of Risk Scores for Lower Gastrointestinal Bleeding: A Systematic Review and Meta-analysis. — Almaghrabi M, Gandhi M, Guizzetti L, et al. JAMA Network Open. 2022.